Showing 321-330 of 1555 results for "".
My Dermatology Wish List
https://practicaldermatology.com/topics/practice-management/my-dermatology-wish-list/18911/What is Dr. Bill Ju's wish for dermatology? The President of Advancing Innovation in Dermatology wants to continue to grow entrepreneurship as a grassroots effort. He'd like to see more support for young ideas and young thinkers.Significant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.PDT vs Topical Therapies for Pre-Cancerous Areas
https://practicaldermatology.com/series/pdt-in-practice/pdt-vs-topical-therapies-pre-cancerous-areas/26992/Dr. Hamza D. Bhatti, a board-certified dermatologist and dually accredited fellowship-trained Mohs micrographic surgeon and cosmetic dermatologic surgeon, discusses the advantages that photodynamic therapy (PDT) offers in terms of downtime and ease of compliance.Eyes Have It: Bloodless Blephs and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/eyes-have-it-bloodless-blephs-and-more/18728/Demand for treatments around the eye continue to grow; patients want big results but little downtime. Dr. Niamtu discusses his "bloodless bleph" and other uses for fillers and toxins.ASDS: Ethics and Social Media Panel Discussion
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-ethics-and-social-media-panel-discussion/29153/Drs. Fatima Fahs, Kavita Mariwalla, DiAnne Davis, and Evan Rieder recap key points from their panel discussion on ethics and social media at the 2024 American Society for Dermatologic Surgery Annual Meeting.What's New in Dermatopathology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/what-s-new-in-dermatopathology/18992/Joshua Zeichner, MD speaks with Clay Cockerell, MD about the latest developments in dermatopathology. Specifically, Dr. Cockerell discusses how new tests may change melanoma diagnosis and change the way dermatopathologists and dermatologists interact.Chronic Hand Eczema
https://practicaldermatology.com/series/updates-atopic-dermatitis/chronic-hand-eczema/29146/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks about chronic hand eczema.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.Skin Reactions: Understanding New Drug Adverse Effects
https://practicaldermatology.com/conferences/aad-summer-2021/skin-reactions-understanding-new-drug-adverse-effects/19975/In addition to needing to stay abreast of new drugs in dermatology, it's important for dermatologists to stay informed about new medications that come to market in general. Vinod Nambudiri, MD, MBA says there are often dermatology-related adverse events that need to be managed. He discusses new cancDermWireTV: LEO Science & Tech Hub, Allergan/SkinBetter DREAM Initiative, San Diego Dermatology Symposium
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-leo-pharma-science-tech-hub-allerganskinbetter-dream-initiative-san-diego-dermatology-symposium/19856/Innovation Endeavors and the LEO Science & Tech Hub kick off a Deep Life Challenge program. Allergan Aesthetics, an AbbVie company, and Skinbetter Science launch a new long-term, educational initiative: The DREAM (Driving Racial Equity in Aesthetic Medicine) Initiative. The San Diego Dermatology